Scarica l'app Stockscreener
17.76
1.28%
-0.23
Dopo l'orario di chiusura:
17.73
-0.03
-0.17%
Precedente Chiudi:
$17.99
Aprire:
$17.9
Volume 24 ore:
366.41K
Relative Volume:
0.57
Capitalizzazione di mercato:
$787.64M
Reddito:
$206.22M
Utile/perdita netta:
$-16.70M
Rapporto P/E:
-46.01
EPS:
-0.386
Flusso di cassa netto:
$-5.55M
1 W Prestazione:
+6.86%
1M Prestazione:
+8.82%
6M Prestazione:
+7.12%
1 anno Prestazione:
+4.29%
Intervallo 1D:
$17.50
$18.27
Intervallo di 1 settimana:
$16.73
$18.65
Portata 52W:
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Nome
Si Bone Inc
Settore
Industria
Telefono
(408) 207-0700
Indirizzo
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
17.76 | 756.16M | 206.22M | -16.70M | -5.55M | -0.386 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | TD Cowen | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-07 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-06-08 | Iniziato | Citigroup | Buy |
| 2021-03-09 | Reiterato | Needham | Buy |
| 2020-12-16 | Reiterato | Needham | Buy |
| 2020-08-04 | Reiterato | Needham | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-05 | Reiterato | Needham | Buy |
| 2020-02-19 | Iniziato | Needham | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Iniziato | BofA/Merrill | Buy |
| 2018-11-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-11-12 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-11-12 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Si Bone Inc Borsa (SIBN) Ultime notizie
SI-BONE Inc (SIBN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SI-BONE Inc (SIBN) Institutional Confidence - TradingKey
SI-BONE Inc (SIBN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SI-BONE Inc (SIBN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SI-BONE Inc (SIBN) Income Statement - TradingKey
SI-BONE Inc (SIBN) Balance Sheet - TradingKey
SI-BONE Inc (SIBN) Cash Flow - TradingKey
SI-BONE Inc (SIBN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SI-BONE Inc (SIBN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SI-BONE Inc (SIBN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SI-BONE, Inc. Revenue Breakdown – FWB:2K3 - TradingView
SI-BONE, Inc. Revenue Breakdown – GETTEX:2K3 - TradingView
SI-BONE Inc (SIBN) Valuation: PE, PB & Fair Value Analysis - TradingKey
SI-BONE Inc (SIBN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SI-BONE to report Q2 2026 results, host conference call - Bitget
Understanding the Setup: (SIBN) and Scalable Risk - Stock Traders Daily
SI-BONE to report second quarter 2026 results on August 3 - scanx.trade
SI-BONE schedules a 4:30 p.m. ET webcast for Aug. 3 - Stock Titan
SIBN Maintained by Truist Securities -- Price Target Raised to $21 - GuruFocus
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $21 - Moomoo
Truist Securities Adjusts Price Target on SI-BONE to $21 From $18, Maintains Buy Rating - marketscreener.com
ViCentra appoints CFO and board member ahead of U.S. expansion - Investing.com UK
ViCentra appoints CFO and board member ahead of U.S. expansion By Investing.com - Investing.com Nigeria
SI-BONE Q1 2026 Earnings: EPS Surges Past Estimates Despite Revenue UncertaintyPre-Earnings Setup - dars.gov.et
Si-Bone SVP Michael Pisetsky sells $52,375 in stock - Investing.com
Si-Bone CFO Anshul Maheshwari sells $55,626 in company stock - Investing.com
Form 4 Si-Bone Inc For: 6 July By Investing.com - Investing.com Nigeria
Si-Bone CFO Anshul Maheshwari sells $55,626 in company stock By Investing.com - Investing.com South Africa
Si-Bone SVP Michael Pisetsky sells $52,375 in stock By Investing.com - Investing.com South Africa
SI-BONE (SIBN) legal officer sells 3,134 shares in RSU tax sell-to-cover - Stock Titan
Si-Bone | 4: Statement of changes in beneficial ownership of securities-Officer PISETSKY MICHAEL A. - Moomoo
SI-BONE (NASDAQ: SIBN) CFO sells shares to cover RSU tax withholding - Stock Titan
Si-Bone Company Profile & Introduction - Moomoo
SIBNSI-BONE Inc Latest SEC Filings - Finviz
Price to book forward of SI-BONE, Inc. – NASDAQ:SIBN - TradingView
Price to sales forward of SI-BONE, Inc. – NASDAQ:SIBN - TradingView
Price to earnings forward of SI-BONE, Inc. – NASDAQ:SIBN - TradingView
SI-BONE Inc. (SIBN) Q1 2026 Earnings: EPS Beats Estimates Significantly Amid Operational ProgressCapex Guidance - dars.gov.et
SIBN Q1 2026 Earnings: EPS Surprises to the Upside with 48% BeatAnalyst Drop Coverage - dars.gov.et
SI-BONE, Inc. Actuals & Estimates (NASDAQ:SIBN) - TradingView
SI-BONE Inc. (SIBN) Attempts to Reclaim Ground After Recent PullbackFactor Crowding - dars.gov.et
SI-BONE Inc. (SIBN) Q1 2026 Earnings: EPS Surprise Drives Positive Market ReactionSegment Revenue Breakdown - dars.gov.et
SI-BONE outlines path to profitability, shares trade on Nasdaq in a volatile medtech sector - AD HOC NEWS
SI-BONE strategy focuses on differentiated sacropelvic implants, shares on Nasdaq in a competitive m - AD HOC NEWS
SIBN Technical Analysis & Stock Price Forecast - Intellectia AI
SI-BONE Inc. (SIBN) Rallies 3.68% as Shares Approach Key Resistance LevelRatio Spread Trade - dars.gov.et
Precision Trading with Si-bone Inc. (SIBN) Risk Zones - Stock Traders Daily
SI-BONE Inc. (SIBN) Q1 2026 Earnings: Narrowed Loss Beats Street Estimates by Wide MarginROA Comparison - dars.gov.et
SIBN: Multi-product innovation, expanded partnerships, and reimbursement tailwinds set up multi-year growth - TradingView
SI-BONE Inc. (SIBN) Gains 1.85% as Stock Tests Key Resistance LevelAI Trade Signals - newsline.com
SIBN Q1 2026 Earnings: Earnings Beat Driven by Strong Operational ExecutionNew Analyst Coverage - newsline.com
Si Bone Inc Azioni (SIBN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Si Bone Inc Azioni (SIBN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Maheshwari Anshul | Chief Financial Officer |
Jul 02 '26 |
Sale |
16.77 |
3,317 |
55,627 |
256,560 |
| DUNN JEFFREY W | Director |
Jun 05 '26 |
Sale |
15.25 |
3,575 |
54,505 |
16,057 |
| Davis Timothy E JR | Director |
May 28 '26 |
Option Exercise |
4.32 |
12,064 |
52,116 |
73,002 |
| Davis Timothy E JR | Director |
May 28 '26 |
Sale |
14.47 |
3,780 |
54,699 |
69,222 |
| Davis Timothy E JR | Director |
May 29 '26 |
Sale |
14.14 |
3,500 |
49,488 |
65,722 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):